LB Pharmaceuticals (LBRX) Proxy filing summary

Executive summary

• Annual Meeting of Stockholders scheduled for June 3, 2026, at 9:30 a.m. Eastern Time, to be held virtually.

• Shareholders are encouraged to review proxy materials and vote by June 2, 2026.

Voting matters and shareholder proposals

• Election of three Class I director nominees to serve until the 2029 Annual Meeting: Robert A. Lenz M.D., Ph.D., Rebecca Luse, and Ran Nussbaum.

• Ratification of BDO USA, P.C. as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Proxies may vote on other business that may properly come before the meeting.

Board of directors and corporate governance

• Board recommends voting in favor of all director nominees and the auditor ratification.